Acrux Limited announced that Dr. Tim Oldham has joined the board as a non-executive director. Tim brings to the board more than a decade of business development, alliance management and sales and marketing experience in Europe, Asia and Australia acquired in senior management roles with Mayne Pharma and most recently as President Asia Pacific for Hospira.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 AUD | -1.30% | -6.17% | +72.73% |
04-03 | Acrux, TruPharma Launch Dapsone 5% Gel in US | MT |
02-29 | Transcript : Acrux Limited, H1 2024 Earnings Call, Feb 29, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+72.73% | 14.55M | |
+19.98% | 43.3B | |
+24.69% | 22.22B | |
+18.92% | 15.43B | |
+22.94% | 14.48B | |
+55.24% | 12.72B | |
-0.05% | 6.79B | |
-10.33% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- ACR Stock
- News Acrux Limited
- Acrux Limited Appoints Tim Oldham as Non-Executive Director